News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
409,969 Results
Type
Article (47902)
Company Profile (79)
Press Release (361988)
Section
Business (118639)
Career Advice (1325)
Deals (16737)
Drug Delivery (44)
Drug Development (50052)
Employer Resources (93)
FDA (8333)
Job Trends (9229)
News (194000)
Policy (15166)
Tag
Academia (2617)
Alliances (34164)
Alzheimer's disease (1097)
Approvals (8361)
Artificial intelligence (140)
Bankruptcy (101)
Best Places to Work (7229)
Breast cancer (152)
Cancer (1222)
Career advice (1103)
CAR-T (86)
Cell therapy (229)
Clinical research (38867)
Collaboration (513)
COVID-19 (1874)
C-suite (89)
Data (1179)
Diabetes (120)
Diagnostics (3864)
Drug discovery (76)
Earnings (42125)
Employer resources (82)
Events (49147)
Executive appointments (360)
FDA (8859)
Funding (392)
Gene therapy (158)
GLP-1 (381)
Government (2285)
Healthcare (11157)
Infectious disease (1944)
Inflammatory bowel disease (86)
Interviews (262)
IPO (7672)
Job creations (2319)
Job search strategy (956)
Layoffs (258)
Legal (2805)
Lung cancer (181)
Lymphoma (86)
Manufacturing (141)
Medical device (6266)
Medtech (6269)
Mergers & acquisitions (9306)
Metabolic disorders (287)
Neuroscience (1377)
NextGen: Class of 2025 (3487)
Non-profit (3642)
Northern California (1187)
Obesity (129)
Opinion (141)
Parkinson's disease (85)
Patents (82)
People (35188)
Phase I (12156)
Phase II (16589)
Phase III (13085)
Pipeline (545)
Postmarket research (1900)
Preclinical (6657)
Radiopharmaceuticals (158)
Rare diseases (180)
Real estate (3932)
Regulatory (11050)
Research institute (2501)
Resumes & cover letters (191)
Southern California (1043)
Startups (2268)
United States (10614)
Vaccines (425)
Weight loss (77)
Date
Today (68)
Last 7 days (407)
Last 30 days (1549)
Last 365 days (20674)
2025 (2670)
2024 (20916)
2023 (24289)
2022 (33903)
2021 (35794)
2020 (33118)
2019 (27532)
2018 (20850)
2017 (19748)
2016 (19636)
2015 (23245)
2014 (17617)
2013 (15587)
2012 (15663)
2011 (16388)
2010 (15184)
Location
Africa (557)
Arizona (82)
Asia (24992)
Australia (4760)
California (2667)
Canada (1055)
China (230)
Colorado (109)
Connecticut (138)
Europe (59582)
Florida (422)
Georgia (91)
Illinois (253)
Indiana (166)
Japan (95)
Maryland (421)
Massachusetts (1944)
Michigan (127)
Minnesota (145)
New Jersey (883)
New York (907)
North Carolina (555)
Northern California (1187)
Ohio (117)
Pennsylvania (557)
South America (618)
Southern California (1043)
Texas (421)
Washington State (317)
409,969 Results for "scripps research calibr division".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Calibr-Skaggs announces expansion of option and license agreement with AbbVie to develop novel cell therapies for solid tumors and autoimmune diseases
The Calibr-Skaggs Institute for Innovative Medicines, the nonprofit drug development division of Scripps Research, announced today that AbbVie (NYSE: ABBV) has expanded its collaboration to further explore Calibr-Skaggs’ switchable CAR-T (sCAR-T) platform in solid tumor indications and autoimmune diseases.
February 6, 2024
·
3 min read
Press Releases
Scripps Research Advances Breakthrough Regenerative Medicines to Reverse Aging-Related Diseases
October 31, 2024
·
6 min read
Deals
Calibre Scientific Acquires DCS, a German Provider of Antibodies, Reagents and Equipment Used in Immunohistochemistry
Calibre Scientific is pleased to announce the acquisition of DCS Innovative Diagnostik-Systeme GmbH & Co. KG (“DCS” or the “Company”), a German supplier of reagents and equipment used in immunohistochemistry for the diagnostic, research, industrial, university and hospital industries, with a focus on clinical pathology and oncology end markets.
June 19, 2024
·
2 min read
Press Releases
Alloy Therapeutics Announces Institutional License Agreement with Scripps Research for its ATX-Gx™ Platform for Fully Human Antibody Discovery
October 30, 2024
·
3 min read
Press Releases
Xenetic Biosciences, Inc. Extends Research and Development Collaboration with The Scripps Research Institute to Advance DNase Platform
November 8, 2024
·
6 min read
Biotech Beach
Calibr and Bill & Melinda Gates Medical Research Institute announce licensing agreement for novel candidate tuberculosis treatment compound
Calibr, a division of Scripps Research dedicated to the “bench to bedside” development of transformative medicines, and the Bill & Melinda Gates Medical Research Institute, announced a strategic licensing agreement to advance development of a novel investigational compound for tuberculosis treatment.
February 15, 2023
·
4 min read
Deals
Calibre Scientific Acquires LineaLAB
Calibre Scientific has acquired LineaLAB, SL, a provider of analytical, bio and laboratory equipment based in Badalona.
January 2, 2024
·
4 min read
Biotech Beach
Bruker Applied Mass Spectrometry Division Showcases High-Performance Solutions for Research and Analysis in Applied Laboratories
The Bruker Applied Mass Spectrometry Division is showcasing some of its latest innovations at ASMS 2024.
June 3, 2024
·
4 min read
Drug Development
Site Survival: Why Clinical Research Sites Need a Lifeline
Elisa Cascade, CPO at Advarra explains why addressing the challenges faced by clinical research sites is vital for improving patient trust and the overall viability of clinical trials.
February 19, 2025
·
1 min read
·
Lori Ellis
Press Releases
Calibre Scientific Acquires Acefesa, a Provider of Laboratory Consumables and Equipment in Spain
August 7, 2024
·
2 min read
1 of 40,997
Next
